Hormonal therapy can effectively enhance the quality of life for postmenopausal women, and prevent climacteric-related conditions such as osteoporosis. Since long-term therapy is often required, compliance becomes an important issue. This can best be achieved by measurement, documenting the reason for hormone therapy, and by repeated measurement, demonstrating a response to the treatment. Case histories documenting this principle are described.2517705PMCnul
Peri- and postmenopause are stages of reproductive aging in women characterized first by ovarian hor...
OBJECTIVE: Postmenopausal bone loss and osteoporotic fractures can be prevented by hormone replaceme...
Postmenopausal osteoporosis is characterized not only by a reduction in bone mass but also by bone m...
The best approach to treatment of osteoporosis is prevention of bone loss as discussed elsewhere in ...
Menopause predisposes women to osteoporosis due to declining estrogen levels. This results in a decr...
Hormonal replacement therapy (HRT) is generally regarded as first choice for pharmacological prevent...
Fracture prevention is one of the public health priorities worldwide. Estrogen deficiency is the maj...
Osteoporosis is a medical, social and economical problem for developed countries. Prevention remains...
We provide an evidence base and guidance for the use of menopausal hormone therapy (MHT) for the mai...
In a three year prospective controlled study 66 postmenopausal women were randomally allocated to re...
BACKGROUND: Menopausal symptoms can be very distressing and considerably affect a woman's personal a...
Objective: Studies show that adherence to osteoporosis treatment and prevention is low, which could ...
This paper considers the hypothesis that modern gynecological practices relating to sex-steroid horm...
The rapid decline in endogenous estrogen production that occurs during menopause is associated with ...
Hormone replacement therapy (HRT) is effective for relieving vasomotor symptoms such as hot flash an...
Peri- and postmenopause are stages of reproductive aging in women characterized first by ovarian hor...
OBJECTIVE: Postmenopausal bone loss and osteoporotic fractures can be prevented by hormone replaceme...
Postmenopausal osteoporosis is characterized not only by a reduction in bone mass but also by bone m...
The best approach to treatment of osteoporosis is prevention of bone loss as discussed elsewhere in ...
Menopause predisposes women to osteoporosis due to declining estrogen levels. This results in a decr...
Hormonal replacement therapy (HRT) is generally regarded as first choice for pharmacological prevent...
Fracture prevention is one of the public health priorities worldwide. Estrogen deficiency is the maj...
Osteoporosis is a medical, social and economical problem for developed countries. Prevention remains...
We provide an evidence base and guidance for the use of menopausal hormone therapy (MHT) for the mai...
In a three year prospective controlled study 66 postmenopausal women were randomally allocated to re...
BACKGROUND: Menopausal symptoms can be very distressing and considerably affect a woman's personal a...
Objective: Studies show that adherence to osteoporosis treatment and prevention is low, which could ...
This paper considers the hypothesis that modern gynecological practices relating to sex-steroid horm...
The rapid decline in endogenous estrogen production that occurs during menopause is associated with ...
Hormone replacement therapy (HRT) is effective for relieving vasomotor symptoms such as hot flash an...
Peri- and postmenopause are stages of reproductive aging in women characterized first by ovarian hor...
OBJECTIVE: Postmenopausal bone loss and osteoporotic fractures can be prevented by hormone replaceme...
Postmenopausal osteoporosis is characterized not only by a reduction in bone mass but also by bone m...